R21 grant
Definition
An R21 is the NIH Exploratory/Developmental Research Grant, which funds early-stage, often high-risk projects for up to two years with up to $275,000 in total direct costs. Preliminary data is not required.
How it works
An R21 funds the exploratory stage of a new idea, such as a new model, technique, or line of inquiry that could lead to a larger project. Key rules for the parent R21, as of October 2026:
- Length. Up to two years.
- Budget. Combined direct costs for both years may not exceed $275,000, and no more than $200,000 may be requested in any single year. Most R21s use a modular budget.
- Preliminary data. Not required, though reviewers may still look for evidence the approach is feasible.
- Application. A one-page specific aims page and a shorter research strategy than an R01 (six pages for most R21s).
- Renewal. R21s cannot be renewed.
Not every NIH institute accepts R21s through the parent announcement, and some use R21s only for specific initiatives, so check the participating institutes in the current notice of funding opportunity. Several institutes joined the parent R21 in 2025 and 2026.
Why it matters for researchers
The R21 matters because it lets a lab test a new direction without the track record an R01 expects, and the results can become the preliminary data for an R01. It is not, however, an easier or "starter" grant: success rates for R21s have historically been similar to or lower than R01 rates, and the award is far smaller. Many research development staff advise early career faculty to weigh an R21 against going straight for an R01.
R21 vs R01
An R21 is a two-year, capped exploratory grant, while an R01 is a longer, larger grant for a well-developed project. Receiving an R21 does not end early stage investigator status, and R21 applications do not get ESI funding priority, which applies to R01-equivalent awards. The R21/R33 is a related phased award that combines an exploratory phase with a follow-on development phase.
Common mistakes
- Proposing an R01-sized project squeezed into an R21 budget.
- Pitching a safe, incremental project when reviewers expect exploratory, potentially high-impact work.
- Applying to an institute that does not participate in the parent R21.
- Treating the R21 as a stepping stone without planning what data the R01 will need.
How Atom helps
Atom reads each R21 notice end to end and checks eligibility for each researcher, and Atom Proposals critiques drafts against NIH study section criteria before submission.
Frequently asked questions
An NIH R21 provides up to $275,000 in direct costs over two years combined, with no more than $200,000 in any single year, plus indirect costs at the institution's negotiated rate.
No. The R21 does not require preliminary data, because it is meant to fund exploratory work. Reviewers still assess whether the approach is feasible.
Not necessarily. R21 success rates have historically been similar to or lower than R01 rates, and the award is much smaller and cannot be renewed.